Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:6840592.
doi: 10.1155/2017/6840592. Epub 2017 Sep 18.

Labor Induction with Orally Administrated Misoprostol: A Retrospective Cohort Study

Affiliations

Labor Induction with Orally Administrated Misoprostol: A Retrospective Cohort Study

Tove Wallstrom et al. Biomed Res Int. 2017.

Abstract

Introduction: One great challenge in obstetric care is labor inductions. Misoprostol has advantages in being cheap and stable at room temperature and available in resource-poor settings.

Material and methods: Retrospective cohort study of 4002 singleton pregnancies with a gestational age ≥34 w at Sodersjukhuset, Stockholm, during 2009-2010 and 2012-2013. Previously used methods of labor induction were compared with misoprostol given as a solution to drink, every second hour. Main outcome is as follows: Cesarean Section (CS) rate, acid-base status in cord blood, Apgar score < 7,5', active time of labor, and blood loss > 1500 ml (PPH).

Results: The proportion of CS decreased from 26% to 17% when orally given solution of misoprostol was introduced at the clinic (p < 0.001). No significant difference in the frequency of low Apgar score (p = 0.3), low aPh in cord blood (p = 0.1), or PPH (p = 0.4) between the different methods of induction was studied. After adjustment for different risk factor for CS the only method of induction which was associated with CS was dinoproston⁎⁎ (Propess®) (aor = 2.9 (1.6-5.2)).

Conclusion: Induction of labor with misoprostol, given as an oral solution to drink every second hour, gives a low rate of CS, without affecting maternal or fetal outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of study design.

Similar articles

Cited by

References

    1. Alkema L., Chou D., Hogan D., et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the un Maternal Mortality Estimation Inter-Agency Group. The Lancet. 2016;387(10017):462–474. doi: 10.1016/S0140-6736(15)00838-7. - DOI - PMC - PubMed
    1. Alfirevic Z., Aflaifel N., Weeks A. Oral misoprostol for induction of labour. The Cochrane database of systematic reviews. 2014;6:p. CD001338. doi: 10.1002/14651858.CD001338.pub3. - DOI - PMC - PubMed
    1. WHO. Guidelines Approved by the Guidelines Review Committee. Geneva, Switzerland: World Health Organization; 2011.
    1. Irani R. A., Foster S. Overview of the mechanisms of induction of labor. Seminars in Perinatology. 2015;39(6):426–429. doi: 10.1053/j.semperi.2015.07.001. - DOI - PubMed
    1. Mozurkewich E. L., Chilimigras J. L., Berman D. R., et al. Methods of induction of labour: a systematic review. BMC Pregnancy and Childbirth. 2011;11, article no. 84 doi: 10.1186/1471-2393-11-84. - DOI - PMC - PubMed

LinkOut - more resources